A randomized phase II trial evaluating the addition of low dose, short course sunitinib to docetaxel in advanced solid tumours

Overview of attention for article published in BMC Cancer, November 2020

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 6 Dimensions

Readers on

mendeley: 27 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 1 X post from an account with 6,217 followers.

.@sundar__raghav @NUSMedicine https://t.co/TBnlKqPAcd

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.